POTSPOTS← ALL GUIDES
GUIDE

What Causes POTS? Subtypes, Triggers and What the Evidence Shows

The mechanisms researchers describe in POTS (low blood volume, hyperadrenergic, neuropathic, autoimmune, deconditioning), the conditions linked to it, and how strong the evidence is for each.

By Kaustubh Dabhadkar, preventive cardiologist · Published October 9, 2026

No single cause explains POTS. Experts describe several overlapping mechanisms, and one person can have more than one. The 2019 NIH consensus calls these categories neither fully inclusive nor mutually exclusive.

The main mechanisms

WHERE IT ACTS: LEG AND BELLY BLOOD VESSELS

Nerves that tell these vessels to tighten work poorly, so blood pools.

At least half of 152 Mayo patients had a sweat test pattern that fits.

Evidence: described in consensus statements
Mechanisms overlap, and one person can have more than one. The figure is an illustration.

152 MAYO CLINIC PATIENTS

Abnormal sweat test (neuropathic pattern)at least 50%
Presumed low blood volumeat least 29%
High standing norepinephrine29%
Mayo Clinic series of 152 patients. One patient can appear in more than one bar.

Fluid and salt strategies target low blood volume. The autoimmune evidence conflicts: commercial antibody tests did not reliably show autoimmunity in the larger 2022 study, so autoimmune POTS remains a research hypothesis for most patients. Rebuilding fitness helps many people, which is why reconditioning exercise features in treatment plans. The 2015 HRS statement lists hypervigilance as a contributor in some patients, and the heart rate changes remain measurable.

Triggers people describe

Clinic cohorts often report viral illness (including COVID-19, see the long COVID guide), surgery, pregnancy, concussion and rapid growth in adolescence. Cause and effect is hard to prove.

Conditions that travel with POTS

  • Met hEDS criteria (31%)
  • Hypermobile without hEDS (24%)
  • Neither
One dot per patient in a 2020 study of 91 people with POTS. Counts rounded from the published percentages.
  • Hypermobile Ehlers-Danlos syndrome and joint hypermobility. The NIH panel estimates 20 to 30%. The link holds up, and the reason for it remains unknown.
  • Mast cell activation. A 2021 study of 69 patients found 42% with symptoms and a lab marker that fit, without a control group. A 2025 systematic review found no study that met its criteria to confirm the link. Treat it as unproven.
  • Migraine, irritable bowel symptoms and chronic fatigue commonly co-occur. Mention them to your doctor.

Why subtype labels matter less than they sound

Subtype names guide research. Clinics start with measures that help most people (fluids, salt, compression, exercise) and add medicines by symptom. Read the treatment overview next.

NOTE

This page informs and does not diagnose. Only a clinician who can examine you and see your whole history can interpret your numbers.

Want a record to bring to your visit? The POTS app guides the stand test at home and graphs your heart rate. See the app

© 2026 CORDOC LLCGuidesWalk-throughCheck numbersTreatmentsResearchVisit prepResourcesThe appPrivacyTerms